A Decade of Added Immune Treatment for Glioblastoma in Real-World Care
Original title: A Multiphase Combined Treatment Including Individualized Multimodal Immunotherapy and Tumor Microenvironment Therapy for Glioblastoma: A Decade of Experience with Real-World Patients.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
Doctors only looked back at records of patients already treated, not a trial.
The short version
Doctors looked back at 104 glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary patients who got extra immune treatments.
What was studied. Doctors reviewed the records of 104 adults with glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary, ages 18 to 70. Everyone had already received a mix of immune treatments, which included heat sessions, NDV shots, and dendritic cell vaccines.
What they found. The patients were split into two groups by a tumor marker called MGMT promoter methylation: MGMT is a gene whose protein repairs damage to a tumor's DNA. Methylation turns it down. Your report says how much, and your team uses that when they choose chemotherapy. The line between high and low is not settled. See the glossary. One group lived 33.1 months and the other lived 19.0 months. At two years, 69.7% of the first group were alive, and 35.4% of the other group were alive. The report found no major side effects, and quality of life stayed steady during treatment.
What this means, and what it doesn't
What it could mean: This kind of care is only open to patients who are still fairly active and who can pay for it. The report is a hopeful sign, and it is something you could ask your own doctor about.
What it doesn't mean: This was not a trial. Doctors simply looked back at patients who had already been treated. No group went without the treatment, so we cannot say the treatment is what made people live longer. It is far from normal care, and it is not a cure.
Source: PubMed, September 11, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.